Literature DB >> 26109257

Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.

Michel Hochuli1,2, Emanuel Christ3, Fabian Meienberg4, Roger Lehmann5, Jan Krützfeldt5, Matthias R Baumgartner6,7.   

Abstract

BACKGROUND: Traditional approaches for nighttime glycemic control in glycogen storage disease type I (GSDI) include continuous tube feeding, or ingestion of uncooked corn starch (CS) at bedtime. A modified corn starch (MCS) has been shown to prolong euglycemia in some patients. The aim of this study was to evaluate whether stable nighttime glucose control can be achieved with other types of slowly digested carbohydrates in adult GSDI patients.
METHODS: In this cross-over study, nocturnal glucose control and fasting times were assessed with three different nocturnal nutrition regimens in five patients, using continuous glucose monitoring (CGMS) in an outpatient everyday life setting. For each patient, continuous glucose profiles were measured after ingestion of (1) CS, (2) MCS or (3) a pasta meal at bedtime, during 5 to 6 consecutive nights for each regimen.
RESULTS: Stable nocturnal glucose control was achieved for all patients with a pasta meal, with a mean duration of glycemia >3.5 mmol/l of 7.6 h (range 5.7-10.8), and >4 mmol/l of 7 h (5.2-9.2), similar to CS and MCS. Fasting glucose before breakfast on workdays (after 7.1 ± 0.8 h) was not significantly different between the three interventions (CS 4.1 ± 0.5 mmol/l, MCS 4.6 ± 0.7 mmol/l, pasta 4.3 ± 0.9 mmol/l). During prolonged fasting on weekends, longer duration of normoglycemia was achieved with CS or MCS than with pasta.
CONCLUSION: Consumption of cooked pasta is a suitable and more palatable alternative to uncooked corn starch to achieve nighttime glucose control in adult patients with GSDI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26109257     DOI: 10.1007/s10545-015-9864-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

Review 1.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

2.  Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease.

Authors:  J I Wolfsdorf; J F Crigler
Journal:  Am J Clin Nutr       Date:  1997-05       Impact factor: 7.045

Review 3.  Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.

Authors:  K K Shah; S D O'Dell
Journal:  J Hum Nutr Diet       Date:  2013-01-07       Impact factor: 3.089

4.  The use of continuous glucose monitoring in the practical management of glycogen storage disorders.

Authors:  Fiona J White; Simon A Jones
Journal:  J Inherit Metab Dis       Date:  2011-05-10       Impact factor: 4.982

Review 5.  Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I).

Authors:  Jan Peter Rake; Gepke Visser; Philippe Labrune; James V Leonard; Kurt Ullrich; G Peter A Smit
Journal:  Eur J Pediatr       Date:  2002-08-24       Impact factor: 3.183

6.  Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.

Authors:  David A Weinstein; Joseph I Wolfsdorf
Journal:  Eur J Pediatr       Date:  2002-07-31       Impact factor: 3.183

7.  A novel starch for the treatment of glycogen storage diseases.

Authors:  K Bhattacharya; R C Orton; X Qi; H Mundy; D W Morley; M P Champion; S Eaton; R F Tester; P J Lee
Journal:  J Inherit Metab Dis       Date:  2007-05-19       Impact factor: 4.982

8.  Continuous glucose monitoring in children with glycogen storage disease type I.

Authors:  Ç S Kasapkara; G Cinasal Demir; A Hasanoğlu; L Tümer
Journal:  Eur J Clin Nutr       Date:  2013-10-23       Impact factor: 4.016

Review 9.  Food properties affecting the digestion and absorption of carbohydrates.

Authors:  I Björck; Y Granfeldt; H Liljeberg; J Tovar; N G Asp
Journal:  Am J Clin Nutr       Date:  1994-03       Impact factor: 7.045

10.  Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics.

Authors:  Priya S Kishnani; Stephanie L Austin; Jose E Abdenur; Pamela Arn; Deeksha S Bali; Anne Boney; Wendy K Chung; Aditi I Dagli; David Dale; Dwight Koeberl; Michael J Somers; Stephanie Burns Wechsler; David A Weinstein; Joseph I Wolfsdorf; Michael S Watson
Journal:  Genet Med       Date:  2014-11       Impact factor: 8.822

View more
  3 in total

1.  Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.

Authors:  Abrar Turki; Sylvia Stockler; Sandra Sirrs; Ramona Salvarinova; Gloria Ho; Jennifer Branov; Annie Rosen-Heath; Taryn Bosdet; Rajavel Elango
Journal:  Mol Genet Metab Rep       Date:  2022-05-11

2.  Enteral tube feeding in patients receiving dietary treatment for metabolic diseases: A retrospective analysis in a large French cohort.

Authors:  Claire-Marine Bérat; Célina Roda; Anais Brassier; Juliette Bouchereau; Camille Wicker; Aude Servais; Sandrine Dubois; Murielle Assoun; Claire Belloche; Valérie Barbier; Virginie Leboeuf; François M Petit; Pauline Gaignard; Elise Lebigot; Pierre-Jean Bérat; Clément Pontoizeau; Guy Touati; Cécile Talbotec; Florence Campeotto; Chris Ottolenghi; Jean-Baptiste Arnoux; Pascale de Lonlay Pascale
Journal:  Mol Genet Metab Rep       Date:  2021-01-05

Review 3.  The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.

Authors:  Anna Rita Cappello; Rosita Curcio; Rosamaria Lappano; Marcello Maggiolini; Vincenza Dolce
Journal:  Front Chem       Date:  2018-04-17       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.